252 related articles for article (PubMed ID: 16253152)
1. The antimicrobial effect of nitric oxide on the bacteria that cause nosocomial pneumonia in mechanically ventilated patients in the intensive care unit.
McMullin BB; Chittock DR; Roscoe DL; Garcha H; Wang L; Miller CC
Respir Care; 2005 Nov; 50(11):1451-6. PubMed ID: 16253152
[TBL] [Abstract][Full Text] [Related]
2. Bacterial isolates from mechanically ventilated patients with nosocomial pneumonia within intensive care unit of a tertiary care center.
Nag VL; Ayyagari A; Venkatesh V; Dash NR; Ghar M; Prasad KN
J Commun Dis; 2005 Dec; 37(4):281-7. PubMed ID: 17278658
[TBL] [Abstract][Full Text] [Related]
3. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
Michalopoulos A; Kasiakou SK; Mastora Z; Rellos K; Kapaskelis AM; Falagas ME
Crit Care; 2005 Feb; 9(1):R53-9. PubMed ID: 15693967
[TBL] [Abstract][Full Text] [Related]
4. Appropriate empiric antimicrobial therapy of nosocomial pneumonia: the role of the carbapenems.
Kollef MH
Respir Care; 2004 Dec; 49(12):1530-41. PubMed ID: 15571647
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit.
Depuydt PO; Blot SI; Benoit DD; Claeys GW; Verschraegen GL; Vandewoude KH; Vogelaers DP; Decruyenaere JM; Colardyn FA
Crit Care Med; 2006 Mar; 34(3):653-9. PubMed ID: 16505649
[TBL] [Abstract][Full Text] [Related]
6. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study.
Michalopoulos A; Fotakis D; Virtzili S; Vletsas C; Raftopoulou S; Mastora Z; Falagas ME
Respir Med; 2008 Mar; 102(3):407-12. PubMed ID: 18060758
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of gaseous nitric oxide in the treatment of skin and soft tissue infections.
Ghaffari A; Jalili R; Ghaffari M; Miller C; Ghahary A
Wound Repair Regen; 2007; 15(3):368-77. PubMed ID: 17537124
[TBL] [Abstract][Full Text] [Related]
8. [Value of aspiration of tracheal secretions and bronchoalveolar lavage in diagnosis of nosocomial pneumonia in ventilated patients].
Schreiber T; Heroldt J; Gottschall R; Klein U
Anaesthesiol Reanim; 1998; 23(4):93-8. PubMed ID: 9789365
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of the combination of levofloxacin plus ceftazidime in the treatment of hospital-acquired pneumonia in the intensive care unit.
Bassetti M; Righi E; Rosso R; Mannelli S; Di Biagio A; Fasce R; Pallavicini FB; Marchetti F; Viscoli C
Int J Antimicrob Agents; 2006 Dec; 28(6):582-5. PubMed ID: 16979877
[TBL] [Abstract][Full Text] [Related]
10. Pneumonia observational incidence and treatment: a multidisciplinary process improvement study.
Brozek J; McDonald E; Clarke F; Gosse C; Jaeschke R; Cook D
Am J Crit Care; 2007 May; 16(3):214-9. PubMed ID: 17460312
[TBL] [Abstract][Full Text] [Related]
11. Combination antibiotic therapy is appropriate for nosocomial pneumonia in the intensive care unit.
Lynch JP
Semin Respir Infect; 1993 Dec; 8(4):268-84. PubMed ID: 7938924
[TBL] [Abstract][Full Text] [Related]
12. [Nosocomial ventilator-associated pneumonia in a tropical intensive care unit].
Diouf E; Beye MD; Diop Ndoye M; Kane O; Seydi AA; Ndiaye PI; Bah MD; Sall KB
Dakar Med; 2006; 51(2):81-8. PubMed ID: 17632982
[TBL] [Abstract][Full Text] [Related]
13. Administration of antimicrobials via the respiratory tract for the treatment of patients with nosocomial pneumonia: a meta-analysis.
Ioannidou E; Siempos II; Falagas ME
J Antimicrob Chemother; 2007 Dec; 60(6):1216-26. PubMed ID: 17934205
[TBL] [Abstract][Full Text] [Related]
14. Microbiologic spectrum and susceptibility pattern of clinical isolates from the pediatric intensive care unit in a single medical center - 6 years' experience.
Lee CY; Chen PY; Huang FL; Lin CF
J Microbiol Immunol Infect; 2009 Apr; 42(2):160-5. PubMed ID: 19597649
[TBL] [Abstract][Full Text] [Related]
15. The role of carbapenems in the treatment of severe nosocomial respiratory tract infections.
Joseph J; Rodvold KA
Expert Opin Pharmacother; 2008 Mar; 9(4):561-75. PubMed ID: 18312158
[TBL] [Abstract][Full Text] [Related]
16. The role of gram-negative bacteria in healthcare-associated pneumonia.
Restrepo MI; Anzueto A
Semin Respir Crit Care Med; 2009 Feb; 30(1):61-6. PubMed ID: 19199188
[TBL] [Abstract][Full Text] [Related]
17. Gaseous nitric oxide bactericidal activity retained during intermittent high-dose short duration exposure.
Miller C; McMullin B; Ghaffari A; Stenzler A; Pick N; Roscoe D; Ghahary A; Road J; Av-Gay Y
Nitric Oxide; 2009 Feb; 20(1):16-23. PubMed ID: 18789393
[TBL] [Abstract][Full Text] [Related]
18. Therapy for ventilator-associated pneumonia: what works, what doesn't.
Hijazi M; Al-Ansari M
Respir Care Clin N Am; 2004 Sep; 10(3):341-58, vi. PubMed ID: 15458732
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and tolerability of amikacin administered as BAY41-6551 aerosol in mechanically ventilated patients with gram-negative pneumonia and acute renal failure.
Luyt CE; Eldon MA; Stass H; Gribben D; Corkery K; Chastre J
J Aerosol Med Pulm Drug Deliv; 2011 Aug; 24(4):183-90. PubMed ID: 21361783
[TBL] [Abstract][Full Text] [Related]
20. Nosocomial pneumonia in a pediatric intensive care unit.
Patra PK; Jayashree M; Singhi S; Ray P; Saxena AK
Indian Pediatr; 2007 Jul; 44(7):511-8. PubMed ID: 17939179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
